Pennington Biomedical's Dr. Philip Schauer Joins the MBS Digest Editorial Board

The MBS Digest welcomed the first of six members to the new editorial board: Dr. Philip Schauer. Dr. Schauer is one of the most-cited and most-referenced researchers in bariatric surgery and metabolic disease. He will be assisting with curating the most relevant articles and news items for our readership.

“I joined MBS Digest because I need help keeping up with the massive influx of innovation in metabolic disease treatment,” Dr. Schauer said.

Dr. Philip R. Schauer is the United Companies Life Insurance Co./ Mary Kay and Terrell Brown Chair endowed Professor of Metabolic Surgery at Pennington Biomedical Research Center and Director of the Metamor Metabolic Institute. Past president of the ASMBS and principal investigator of the landmark STAMPEDE trial, which established metabolic surgery as a durable treatment for type 2 diabetes. He has performed more than 9,000 operations across five continents and authored over 500 papers with more than 53,000 citations.

Dr. Schauer's clinical interests include obesity, diabetes and metabolic surgery. His research interests include the pathophysiology of obesity and type 2 diabetes, and outcomes of metabolic surgery.

He is ranked No. 1 in the world as an expert in bariatric surgery by Expertscape.

The MBS Digest is a product of the Metabolic and Bariatric Surgery Group, LLC. For more information, visit http://mbs-digest.com.

About the Pennington Biomedical Research Center

The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of obesity, diabetes, cardiovascular disease, cancer and dementia. Pennington Biomedical has the vision to lead the world in promoting nutrition and metabolic health and eliminating metabolic disease through scientific discoveries that create solutions from cells to society. The Center conducts basic, clinical and population research, and is a campus in the LSU System.

The research enterprise at Pennington Biomedical includes over 600 employees within a network of 44 clinics and research laboratories, and 16 highly specialized core service facilities. Its scientists and physician/scientists are supported by research trainees, lab technicians, nurses, dietitians and other support personnel. Pennington Biomedical is a globally recognized state-of-the-art research institution in Baton Rouge, Louisiana. For more information, see www.pbrc.edu.